Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ARDS in Children and ECMO Initiation Strategies Impact on Neurodevelopment (ASCEND)

NCT05388708 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT05388708
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05388708 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ARDS in Children and ECMO Initiation Strategies Impact on Neurodevelopment (ASCEND)
Lead sponsor
University of Michigan
Phase
Observational
Overall status
Active, not recruiting
Start date
February 4, 2021
Completion date
September 30, 2027
Enrollment
550 (estimated)
Sites
95

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome, extracorporeal membrane oxygenation